Obesity is one of the most important public health problems, and it is increasing in prevalence worldwide (1, 2) . Obesity is an inflammatory disease that involves many systems in the body, especially the respiratory system, causing changes in pulmonary functions (2). Chronic obstructive pulmonary disease (COPD) is also an important public health problem usually accompanied by nutritional abnormalities (3, 4). The majority of COPD patients are overweight or obese rather than normal or low-weight (4). Obesity and COPD cause mortality and morbidity all over the world, and this global outbreak is predicted to be much higher in the future (5). Obesity might be the reason for respiratory symptoms alone due to decreased pulmonary compliance, increased work in breathing, and increased need for oxygen, even without airway obstruction. However, obesity might also increase the numbers of obstructed peripheral airways (6). It was determined that dyspnea perception is enhanced, health status is impaired, and quality of life (QOL) is reduced in obese COPD patients compared to non-obese COPD patients (7, 8) . It has been shown that pulmonary rehabilitation (PR) reduces dyspnea, enhances exercise performance, improves QOL, and decreases psychological symptoms in COPD patients (9). The present study aimed to compare the gains of PR in obese, pre-obese, and normal-weight COPD patients who completed an 8-week outpatient PR program. 
INTRODUCTION

METHODS
Chronic obstructive pulmonary disease patients (n=265) referred to the Pulmonary Rehabilitation Unit between January 2013 and May 2016 were retrospectively reviewed from the hospital's database. This retrospective cohort study was approved by our hospital's ethics committee. The flowchart of the study is shown in Figure 1 . After acceptance of the PR program, data from 208 patients with COPD who started the program were studied. Patients were excluded because of lack of PR coherence (lack of motivation, transportation problems, and symptom exacerbations). Also, patients were excluded if they had a BMI <21 or >40 kg/m 2 . Finally, a total of 137 COPD patients (122 males) who completed the PR program were enrolled in the study. Demographic characteristics and clinical features of the patients as well as smoking history were obtained from the database. All study participants were called by phone and informed about the aim of study and analysis methods, and their consent for participation was obtained. The patients were questioned in detail about comorbidities. Diabetes mellitus, hypertension, and coronary artery disease were evaluated from medical records. All patients routinely underwent pulmonary and cardiac system examination and pulmonary function tests (PFT) before and after PR. Chest X-rays and arterial blood gases were evaluated. According to the World Health Organization criteria for body mass index (BMI), the patients were classified as normal-weight (BMI=18.5-24.9 kg/m 2 ), pre-obese (BMI=25-29.9 kg/m 2 ), or obese (BMI=30-39.9 kg/m 2 ) (10) . COPD patients with BMI <21 had undergone a supportive nutrition program, so these patients were excluded from the study. COPD severity was classified according to The Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria as mild, moderate, severe, or very severe (11) .
Respiratory Functions: Body plethysmography (Zan 500, Germany) and carbon monoxide diffusion capacity (TLCO) (Zan 300, Germany) were measured and recorded before and after PR.
Assessment of Dyspnea:
The Modified Medical Research Council (MMRC) dyspnea scale, which consists of five items ranging between 1 and 5, was used to determine the severity of patients' shortness of breath (12) . The score "1" represents the best level, and the score "5" indicates the poorest.
Exercise Capacity: The patients underwent a 6-min walk test, and the 6-min walk distance (6MWD) was obtained from the database recorded before and after PR (13) . The walkwork value was obtained by multiplying the patient's walking distance by their body weight according to the formula in (14) .
Psychological Symptoms:
The Hospital Anxiety and Depression (HAD) scale, which consists of 14 questions, was used to determine the patients' psychological status (15) . A HAD score of 0-7 indicates normal, 8-11 indicates borderline disease, and >11 indicates the presence of anxiety or depression.
Quality of Life:
St. George's Respiratory Questionnaire was used to determine disease-specific QOL (16) . High scores define worsened disease and increased symptoms. Overall QOL was assessed by the SF-36 QOL Questionnaire (17) . Increased scores were considered in favor of improved QOL. PR and physiotherapy sessions, lasting 2 h, were performed twice a week for eight weeks to all patients that joined the program. The exercise program included breathing exercises, relaxation and stretching exercises, peripheral muscle strength training, and aerobic exercises. Breathing exercises consisted of pursed-lip breathing, diaphragmatic breathing, and thoracic expansion exercises. In addition, bronchial hygiene techniques and dyspnea-reducing positions were taught. Aerobic exercises were performed on a treadmill or bicycle for 30 min. An arm ergometer was used for the patients with joint disorders or anatomical lower extremity disability. Exercise intensity was predetermined to be 60-90% of the maximum heart rate. Exercise intensity was gradually increased taking the severity of dyspnea as the basis. An intermittent exercise program with oxygen support was performed in the hypoxic or hypercapnic patients with severe COPD. All patients were informed about the importance of continuing exer- Figure 1 . Flowchart of the study cising at home. Patients were reevaluated at the end of 8th week in terms of all parameters.
Statistical Analysis
Statistical analyses were performed with the SPSS 17.0 program (Statistical Package for the Social Sciences Inc.; Chicago, Illinois, USA). The normality of the data was evaluated by the Kolmogorov-Smirnov test. Results are shown as the change between post-treatment and baseline values (Δ values). The Kruskal-Wallis H-test followed by the Mann-Whitney U-test with Bonferroni correction was used for intergroup comparisons. The variables before and after PR were compared in each group with the Wilcoxon Signed Rank Test. A p-value < 0.05 is considered significant.
RESULTS
The study group consisted of 44 normal-weight, 52 pre-obese, and 41 obese COPD patients. Demographic features and differences between three groups before PR are shown in Table 1 . Each group was similar in terms of gender distribution (p=0.958). Age, gender, GOLD stage, smoking consumption, exacerbation history, arterial blood gas, 6MWD, and QOL scores did not differ between the three groups (p>0.05, Table  1 ). The prevalence of hypertension was significantly higher in preobese and obese patients as compared to the normal-weight patients (p=0.008, Table 1 ). Also, as expected, diabetes mellitus was significantly more prevalent in obese patients compared to normal-weight and pre-obese patients (p<0.001, Table 1 ). TLCO was significantly lower in normal-weight patients as compared to pre-obese and obese patients (p<0.001, Table 1 ), but there was no significant difference between the groups in terms of 6MWD (p=0.761, Table 1 ). The walkwork value was significantly higher in obese patients as compared to both pre-obese and normal-weight patients (p=0.003 and p<0.001, respectively, Table  1 ). When comparing post-PR outcomes with the baseline values, we found that forced expiratory volume in the first second (FEV 1 ) was significantly increased in normal-weight and pre-obese patients, whereas the increase in obese patients was not considered significant. None of the groups had a significant change in PFT results after PR (p>0.05, Table 2 ). Partial arterial oxygen pressure (PaO 2 ) and arterial oxygen saturation (SaO 2 ) were significantly increased in all groups, but the change in partial carbon dioxide pressure (PaCO 2 ) was not significant in any of the groups (p>0.05, Table 2 ). The 6MWD and walkwork values were significantly increased and dyspnea scores were significantly decreased in all groups after PR (p<0.001, Table 2 ). Each group showed significant improvement in all scores of disease-related QOL and in most of health-related QOL scores after PR (p<0.05, Table 2 ). In the normal-weight patients, both anxiety and depression scores were significantly decreased after PR (p<0.001 and p=0.003, respectively, Table  2 ); however, a significant decrease was determined only in the anxiety scores in pre-obese patients (p=0.054, Table 2 ). There was no significant decrease in depression scores in obese patients (p>0.05, Table 2 ).
When comparing the three groups in terms of post-PR benefits, it was observed that the increase in 6MWD was significantly lower in obese patients than normal-weight and pre-obese patients (p=0.049, Table  3 , Figure 2 ). Other improvements were similar in each group (p>0.05, Table 3, Figure 3 ).
DISCUSSION
In the present study, although 6MWD was similar in each group before PR, the walkwork value was higher in the obese patients. After PR there were similar benefits in all groups with the exception of the increase in 6MWD. The gain in 6MWD was significantly lower in obese patients as compared to pre-obese and normal-weight patients.
In obese subjects, fat tissue accumulates in the chest wall, diaphragm, and abdomen and alters respiratory mechanics. Accumulated fat reduces lung volume and decreases airflow by mechanically compressing the chest wall, diaphragm, and lungs (2) . In addition, cytokines such as IL-6, which are released from visceral adipose tissue, cause systemic inflammation involving many systems, primarily the respiratory system (2) . There is conflicting data regarding PFTs in obese patients. One study found no difference between normal-weight and obese patients in terms of FEV 1 and FEV 1 /Forced vital capacity (FVC) values (18) , whereas another study found FEV 1 values to be significantly lower in normal-weight patients as compared to the overweight and obese patients (19) . Moreover, in another study both FEV 1 and FEV 1 /FVC values were found to be significantly higher in obese versus non-obese patients (20) . In our study, there was no significant difference between the groups in terms of FEV 1 values, but the FEV 1 / FVC value was significantly higher in the obese patients. This finding might be due to the decreased FVC levels in obese patients. Similar to the literature (18), we found that the TLCO value was significantly higher in the obese patients. This might have resulted from increased pulmonary blood volume in the obese patients (21) .
In our study, we observed significantly higher PaCO 2 in the obese patients, but there was no significant difference between the groups in terms of PaO 2 or SaO 2 . The ventilation-perfusion ratio in obese patients is impaired due to micro-atelectasis in the basal segments of the lungs, and gas exchange is unfavorably influenced leading to impaired oxygenation. Partial oxygen pressure might mildly decrease, while PaCO 2 is mildly increased (22) . In obese patients, dyspnea might be due to increased respiratory load and decreased static lung volume (23) .
In the majority of previous studies, dyspnea scores were found to be higher in obese subjects compared to normal-weight subjects (7, 8) . However, there are studies demonstrating no difference between obese and normal-weight patients in terms of dyspnea (21) . In the present study, dyspnea scores were similar in each group. Not all of the above studies take the COPD severity into account, and in our study the MMRC scores might reflect the COPD severity, which was similar in all three groups. Exercise intolerance might increase in obese subjects due to increased metabolic need and mass load (5) . Owing to the different body weights, the walkwork value shows differences among individuals. In one study, it was determined that the walkwork value reflects the patients' functional capacity better than the other tests. (14) . In two studies, which examined the patients in three groups as normal-weight, overweight, and obese, the 6MWD was found to be significantly lower in the obese patients with significantly higher walkwork values (3, 20) . In one study that investigated the patients in two groups as obese and non-obese, there was no significant difference between the walkwork values, while the 6MWD was significantly lower in the obese patients (20) . Another study show no decrease in the exercise capacity in the obese patients versus normal-weight patients (21) . In our study, 6MWD was not significantly different before PR, but the walkwork value was significantly higher in the obese COPD patients as compared to the other two groups. Thus we might conclude that obese COPD patients must do more "work" to complete the same 6MWD.
It has been demonstrated that PR programs significantly improve the clinical parameters in COPD patients such as physiological and clinical tolerance and dyspnea as well as health-related QOL (22) . For this reason, PR is considered to be one of the most efficient nonpharmacological methods in the treatment of COPD patients (24) . Changes in pulmonary functions after PR show variation, however, and there are studies reporting no change in pulmonary functions (25, 26) as well as the studies reporting increased FEV 1 values after PR (27) (28) (29) . In our study, there was a significant increase in FEV 1 values in the normal-weight and pre-obese patients, whereas the increase in obese patients was not significant. We believe that it can be more difficult to gain in FEV 1 if there is an increased respiratory load on lung volumes in obese COPD patients. 
Decreased exercise tolerance is the main characteristic of COPD patients, and increasing exercise tolerance is the primary goal of PR (30) . Earlier studies demonstrated increased exercise capacity after PR (27) (28) (29) . One study, which evaluated exercise capacity using an incremental shuttle walk test and endurance shuttle walk test by grouping the patients according to BMI found that the baseline ISWT value was significantly lower in obese patients and that there was a significant increase in all groups after PR, but the difference between the groups was not significant (31) . According to the study that evaluated the COPD patients in two groups as obese and non-obese, obese patients showed lower but not statistically significant improvement in ISWT after PR, but the walkwork value was found to be significantly higher (20) . In our study, the 6MWD and walkwork values were significantly increased in all three groups. Comparing the changes between the groups, the increase in 6MWD was significantly lower in the obese group, but there was no difference between the groups in terms of the increase in walkwork value. So, even obese COPD patients significantly but also clinically improve in exercise capacity Table 3 . The comparison of differences after pulmonary rehabilitation between groups after PR. But this gain, which is smaller than the normal-weight COPD patients' gain, requires nearly the same walkwork.
In light of these findings, we suggest that PR is an essential but not sufficient intervention for obese COPD patients. We believe that weight loss should be consistently encouraged in order to increase the benefit of PR in obese COPD patients. Decreased physical activity in COPD patients brings along psychological problems, which are associated with impaired QOL (32) . It is known that PR improves the psychological status of COPD patients and enhances QOL (33) . In the present study, all parameters of disease-related QOL were improved in all groups. With regard to the health-related QOL questionnaires, improvement was observed in all parameters in the normal-weight group and in most of the parameters in the pre-obese and obese groups.
There is a two-sided relationship between obesity and depression; while obesity increases the risk of developing depression, depression might be the precursor of obesity (22) . Both depression and anxiety scores were significantly decreased in normal-weight patients, whereas only the anxiety scores were decreased in pre-obese and obese patients without a significant change in depression score. This might suggest that depression usually occurs due to excessive weight.
There were some limitations to this study. We could not include COPD patients with BMI below 21 or above 40 kg/m 2 in our study. Thus our study does not give any information about cachexic and morbidly obese patients. Moreover, we could not evaluate the body composition with a comprehensive method such as bioelectrical impedance. Therefore, a number of parameters related to body composition such as lean body mass, body fat ratio, and regional fat distributions could not be evaluated.
CONCLUSION
Pre-obese and obese patients benefit from PR similarly compared to the normal-weight patients in terms of gas exchange, dyspnea scores, and QOL scores. However, FEV 1 % was not improved in the obese patients after PR, and the gain of 6MWD was significantly lower in obese patients as compared to pre-obese and normal-weight patients. Further studies are needed to assess the PR outcomes in obese COPD patients. 
